FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
Tandem Diabetes (NASDAQ: TNDM) reported Q3 EPS of ($0.15), $0.05 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $123.6 million versus the consensus estimate of $114.95 million.
Third Quarter 2020 Highlights
In comparing the third quarter of 2020 to the same period of 2019:
Worldwide pump... More
